{"SPADE_UN_10948": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2002/0137896 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2002_0137896_A1", "Patent Type": "Patent Application", "Publication Date": "2008-1-1", "Family Info": "US6291648,US6762296", "Patent Title": "Antitumor protein and gene encoding same.", "Abstract": "An objective of the present invention is to provide an antitumor protein and a gene encoding the same. The specification discloses a protein comprising (a) an amino acid sequence of SEQ ID No.1 or (b) a modified amino acid sequence of SEQ ID No.1 which have antitumor activity wherein one or more amino acids are added and/or inserted into the amino acid sequence of SEQ ID No.1 and/or one or more amino acids in the amino acid sequence of SEQ ID No.1 are substituted and/or deleted."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10948", "Sequence": "VHNFNNLWVGGNGCIPDATACNPTRTSVAYALK", "Sequence Length": 33, "Peptide Name": "Sequence 16 from Patent US 20020137896", "Source": "Synthetic construct", "Biological Activity": ["Antitumor"], "Frequent Amino Acids": "NAG", "Absent Amino Acids": "EMOQU", "Basic Residues": 3, "Acidic Residues": 1, "Hydrophobic Residues": 15, "Polar Residues": 22, "Positive Residues": 3, "Negative Residues": 1, "Mass": 3504.91, "PI": 8.03, "Net Charge": 2, "Hydrophobicity": -0.07, "Similar Sequences": []}}}